Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 35 Nice 32 Marseille 28 Toulouse 26 Montpellier 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris602 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild66 AstraZeneca64 Institut National de la Santé Et de la Recherche Médicale, France63 Clear sponsor filter
Site location
Paris35 Nice32 Marseille28 Toulouse26 Montpellier23
All 72 locations
Target enrolment
to

Trials with a site in Paris

35 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
AbbVie
Phase 2/3
660
Nice, Marseille, Pessac, Angers, Amiens, Paris
2026-06-30
Recruiting
AbbVie
Phase 1
18
Bordeaux, Paris
2026-05-20
Recruiting
AbbVie
Phase 2/3
490
Marseille, Brest, Lille, Montpellier, Paris
2025-12-10
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
AbbVie
Phase 1/2
325
Montpellier, Poitiers, Toulouse, Nantes, Paris
2025-07-23
Active, closed
AbbVie
Phase 3
573
Nice, Montpellier, Créteil, St-Priest-en-Jarez, Paris
2025-06-17
Recruiting
AbbVie
Phase 2
110
Caen, Plérin, Vandœuvre-lès-Nancy, Lille, Nice, Pierre-Bénite, La Roche-sur-Yon, Paris
2025-05-28
Recruiting
AbbVie
Phase 2
390
Lille, Poitiers, Nantes, Paris
2025-04-24
Recruiting
AbbVie
Phase 1/2
252
Bordeaux, Saint-Herblain, Montpellier, Nice, Villejuif, Paris
2025-03-06
Active, closed
AbbVie
Phase 3
699
Toulouse, Vandœuvre-lès-Nancy, Bordeaux, Nantes, Clermont-Ferrand, Amiens, Paris, Argenteuil
2024-08-19
Active, closed
AbbVie
Phase 3
111
Caen, Bron, Paris
2024-08-08
Recruiting
AbbVie
Phase 3
170
Metz, Créteil, Paris, St-Priest-en-Jarez, Nice, Bayonne, Chambéry, Amiens
2024-08-05
Active, closed
AbbVie
Phase 2
108
Marseille, Tours, Paris, Pierre-Bénite, Le Mans
2024-07-29
Active, closed
AbbVie
Phase 3
1,400
Lyon, St-Priest-en-Jarez, Martigues, Rouen, Paris, Reims
2024-06-27
Active, closed
AbbVie
Phase 2/3
167
Marseille, La Tronche, Paris, Bron, Créteil
2024-04-10
Recruiting
AbbVie
Phase 3
110
Tours, Bordeaux, Toulouse, Bron, Paris
2023-12-11
Active, closed
AbbVie
Phase 3
122
Bordeaux, Bron, Paris, Toulouse
2023-11-06
Active, closed
AbbVie
Phase 3
1,014
Toulouse, Lyon, Paris
2023-07-25
Active, closed
AbbVie
Phase 1
135
Bordeaux, Montpellier, Lille, Nantes, Villejuif, Paris
2023-06-09
Recruiting
AbbVie
Phase 1
210
Marseille, Créteil, Nantes, Pierre-Bénite, Poitiers, Paris
2023-03-21
Active, closed
AbbVie
Phase 3
520
Strasbourg, Marseille, Dijon, Brest, Lyon, Paris
2023-03-15
Recruiting
AbbVie
Phase 3
768
Marseille, Lille, Montpellier, Pessac, Paris, Avignon, Bron, Lyon
2022-03-25
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Active, closed
AbbVie
Phase 1
520
Bordeaux, Saint-Herblain, Nice, Lyon, Villejuif, Dijon, Paris
2021-10-13
Active, closed
AbbVie
Phase 1
81
Marseille, Bordeaux, Paris, Dijon, Toulouse
2021-02-23
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Active, closed
AbbVie
Phase 1
85
Nice, Amiens, Paris, Toulouse
2019-11-08
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
AbbVie
Phase 1
150
Saint-Herblain, Paris, Lyon, Clermont-Ferrand
2019-05-21
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
AbbVie
Phase 2
156
Limoges, Tours, Nantes, Villejuif, Poitiers, Paris
2018-04-02
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Amiens, Besançon, Marseille, Paris, Pessac
2018-01-02
Active, closed
AbbVie
Phase 3
443
Pessac, Angers, Paris, Toulouse
2017-02-02
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Active, closed
AbbVie
Observational
1,446
Bron, Paris
2014-08-28
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

12 of the 35 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 35 studies
PhaseStudiesRecruitingShare
Phase 315442.9%
Phase 17220%
Phase 25214.3%
Phase 1/24211.4%
Phase 2/3328.6%
Observational102.9%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
AbbVie3512
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.